Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-02-09

Clinical Trial Update: Effectiveness of Olopatadine HCl Ophthalmic Solution for the Treatment of Allergic Conjunctivitis in Japan [Phase 4]

View source ↗

Summary

Phase 4 trial in Japan evaluating the effectiveness of olopatadine HCl ophthalmic solution for allergic conjunctivitis has completed and results were posted in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • olopatadine HCl ophthalmic solution (olopatadine hydrochloride)

Snippet

Sponsor: Alcon Research | Conditions: Allergic Conjunctivitis | Phase 4 | Status: COMPLETED | Results posted: 2015-02-09